Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00016
|
|||||
| Drug Name |
Meperidine
|
|||||
| Synonyms |
1-Methyl-4-phenyl-4-piperidinecarboxylic acid ethyl ester; 1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester; 1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester [German]; 1-Methyl-4-phenylisonipecotic acid, ethyl ester;1-Methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester; 4-Carbethoxy-1-methyl-4-phenylpiperidine; 4-Piperidinecarboxylic acid, 1-methyl-4-phenyl-, ethyl ester; Demarol; Demerol; Demerol (TN); Dolcontral; Dolosal; Dolsin; Ethyl 1-methyl-4-phenylisonipecotate; Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate; Isonipecain; Isonipecaine; Isonipecotic acid, 1-methyl-4-phenyl-, ethyl ester; Lidol; Lydol; Meperidine solution; Meperidol; Methyl phenylpiperidine carbonic acid ethyl ester; N-Methyl-4-phenyl-4-carbethoxypiperidine; Nemerol; Operidine EPJ I; Operidine EPJ-I; Pethanol; Pethidin; Pethidine; Pethidine (INN); Pethidine DBL; Pethidine DBL (TN); Pethidineter; Pethidinum; Pethidinum [INN-Latin]; Petidina; Petidina [INN-Spanish]; Petydyna; Petydyna [Polish]; Phetidine; Piperosal; Pipersal; YIsonipecotic acid, 1-methyl-4-phenyl-, ethyl ester (8CI)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Moderate to severe pain [ICD11: MG30-MG3Z] | Approved | [1] | |||
| Therapeutic Class |
Anesthetics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C15H21NO2
|
|||||
| Canonical SMILES |
CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
|
|||||
| InChI |
InChI=1S/C15H21NO2/c1-3-18-14(17)15(9-11-16(2)12-10-15)13-7-5-4-6-8-13/h4-8H,3,9-12H2,1-2H3
|
|||||
| InChIKey |
XADCESSVHJOZHK-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 57-42-1
|
|||||
| Pharmaceutical Properties | Molecular Weight | 247.33 | Topological Polar Surface Area | 29.5 | ||
| Heavy Atom Count | 18 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
2.5
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103184537
, 103936336
, 104305308
, 10527888
, 11336158
, 11361397
, 11462369
, 126407782
, 129659418
, 134337544
, 134970866
, 137003750
, 140053016
, 14823367
, 160963800
, 175267872
, 177513108
, 178103795
, 179148680
, 184546706
, 223440287
, 224511988
, 226413511
, 241102133
, 24882043
, 249933926
, 29223169
, 4359668
, 46506899
, 47736577
, 48416212
, 49986147
, 50185474
, 53789706
, 57322120
, 57651808
, 7978480
, 8152545
, 841258
, 85209612
, 9338
, 96025030
|
|||||
| ChEBI ID |
ChEBI:6754
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Meperidine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Opioids and efflux transporters. Part 3: P-glycoprotein substrate activity of 3-hydroxyl addition to meperidine analogs. Bioorg Med Chem Lett. 2008 Jun 15;18(12):3638-40. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.